ArticleInternational journal of legal medicine2026
Differential diagnosis of acute myocardial infarction based on plasma Exosomal MicroRNA.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectThe differentiation of acute myocardial infarction (AMI) has long been a challenging problem in clinical diagnosis and forensic identification. Recent studies have shown that microRNAs (miRNAs) in exosomes are involved in the development and progression of AMI. results indicated that plasma exosomal miRNAs can be considered as novel biomarkers for early AMI recognition.
methodIn this study, exosomal miRNAs in plasma associated with the pathogenesis of AMI was explored and AMI identification model based on these miRNAs were established using machine learning technology.
resultFollowing the analysis of differentially expressed miRNAs in plasma-derived exosomes, the expression levels of 36 miRNAs increase with the passage of time, including miR-3473, miR-504, miR-490-5p, miR-218a-2-3p, and miR-760-3p, showed an increasing trend over time in the plasma exosomes of AMI rats. Based on machine learning techniques, miR-3473, miR-504, miR-490-5p, miR-218a-2-3p were used to construct a model for recognizing early AMI. The precision of the AMI identification model reached 0.955.
conclusionThe results indicated that plasma exosomal miRNAs can be considered as novel biomarkers for early AMI recognition.
Indexed as
Identifiers
40850945What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.